PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors

Patients with advanced-stage gastroenteropancreatic neuroendocrine tumors (GEP-NETs) have a poor overall prognosis despite chemotherapy and radiotherapy (e.g., peptide receptor radionuclide therapy (PRRT)). Better treatment options are needed to improve disease regression and patient survival. The p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Chow, Zeta, Johnson, Jeremy, Chauhan, Aman, Izumi, Tadahide, Cavnar, Michael, Weiss, Heidi, Townsend, Courtney M., Anthony, Lowell, Wasilchenko, Carrigan, Melton, Matthew L., Schrader, Jörg, Evers, B. Mark, Rychahou, Piotr
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8160730/
https://ncbi.nlm.nih.gov/pubmed/34065268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10051261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados